Skip to content

Research compound · identity guide · regulatory review 2026-10-09

Testagen

Short-peptide or bioregulator product name. The exact sequence and preparation must be established from the current label.

Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock.

Editorial review 2026-10-10. source-curated; clinician review pending.

FDA product
not established
Compounding
not established
Research
source limited
Sport
unknown

What is Testagen?

Other names in the library: Testagen. Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: no listed milligram sizes in the vendor file. A seller title is a listing. It does not prove the vial matches a paper.

In plain language

Testagen is listed here as a identity guide. Short-peptide or bioregulator product name. The exact sequence and preparation must be established from the current label. Status was checked 2026-10-09. This card reports cited facts. It does not tell you to use Testagen or how much to take.

What the evidence says

For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.

Regulatory context

Regulatory context; not efficacy evidence

No matched controlled patient-efficacy study of this exact supplier preparation was verified.

Reported findings. Background context only. Matched evidence for the exact marketed formulation is not established by this reference.

Nonresponse. Nonresponse frequency not established in this excerpt.

Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.

Limits. Mechanistic or cellular bioregulator research cannot establish a clinical benefit for this supplier product.

Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Lab or animal research

Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA.

HeLa cells and deoxyribooligonucleotide/DNA assays; no treated patients.

Reported findings. Labelled-peptide nuclear/cytoplasmic fluorescence and sequence-dependent nucleic-acid interactions were reported.

Nonresponse. No testosterone, fertility or patient benefit outcome was measured.

Harms. Human adverse outcomes or safety were not measured.

Limits. FITC labelling, fluorescence quenching and laboratory exposure limit inference about intact commercial peptide uptake. An inconsistent discussion sentence involving alanine does not override the KEDG identity stated in methods. Mechanistic interactions are not evidence of clinical androgen effects.

Preparation: Experimental Lys-Glu-Asp-Gly (KEDG); FITC-labelled peptide for HeLa exposure plus intact-peptide cell-free nucleic-acid assays. Route: Cell culture and cell-free incubation; no therapeutic delivery route.

Read original source ↗

Editorial review 2026-10-10. Clinician review pending.

Clinical observation

Efficacy of testosterone synthesis inductor application Testagen in androgenic deficiency in patients with chronic abacterial prostatitis

36 men aged 38–49 with chronic abacterial prostatitis IIIA and low testosterone; 20 add-on recipients versus 16 standard-treatment recipients.

Reported findings. Authors reported symptom/uroflow and testosterone improvements during 30-day treatment, with larger reported changes in the add-on group.

Nonresponse. Both groups improved; testosterone significance annotations compare with baseline rather than establishing a between-group treatment effect.

Harms. Adverse-event outcomes and systematic harms assessment were not reported; absence of reporting is not demonstrated safety.

Limits. Randomization/blinding were not described; tamsulosin and rectal diclofenac were co-interventions. The table supplies one baseline testosterone value of 7.1 nmol/L and post-treatment values of 7.5 standard versus 9.8 add-on; these are not group-specific baseline changes or a verified causal effect. Baseline leukocyte count is 20.8 in body versus 28.2 in the table; inconsistent time-to-peak wording also limits interpretation. This oral complex is not verified as the injectable catalog KEDG preparation. ClinicalTrials.gov NCT02733133 concerns topical Testagen TDS 5% testosterone, an unrelated compound; it must not support this product.

Preparation: FirmaVita oral food-supplement capsules containing AKS-S peptide complex listing lysine, glutamate, aspartate and glycine; purified KEDG identity/equivalence is unverified. Route: Oral supplement added to standard treatment; not injectable purified Testagen.

Read original source ↗

Editorial review 2026-10-09. Clinician review pending.

Regulatory status, dated 2026-10-09

FDA product approval

not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.

Compounding

not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.

Research

source limited. No matched controlled patient-efficacy study of this exact supplier preparation was verified.

Sport

unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.

How long it lasts, how you store it, listed sizes

This entry doesn’t give a duration in hours. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.

Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.

This card has no units chart until a milligram size is listed.

Risks and mix-ups already on the record

  • Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
  • No complete contraindication list is established for this exact preparation. Review pregnancy, allergies and existing conditions with a clinician.
  • No complete interaction study for this exact preparation is verified. Ingredient combinations are not presumed compatible.

People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.

Sources

  1. Regulatory context; not efficacy evidence · checked 2026-10-09

Questions people ask

Is Testagen FDA-approved?

not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.

Does PepBear pick an amount of Testagen?

The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.

Related cards

Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.

Optional merchant comparison

Where to buy Testagen

Compare the same identity, formulation and format. Blends, oral products and different variants stay separate. A lower price does not establish product quality or medical suitability.

We earn a commission when you buy through PepStar LLC partner links or codes RICHPEP and PEPBEAR. Merchant listings are separate from the evidence and do not establish product quality or medical suitability.

Other dated listings with incomplete quantity or equivalence verification (1)

Individual listing · equivalence unverified

Testagen product listings. Prices exclude unverified shipping and tax.
Price / savingsProduct / quantityTerms / availabilityAction
Price unavailableProduct subtotal. Shipping and tax excluded where unverified.TestagenLimitless Life NootropicsFormulation not verified · format not verifiedQuantity not verified. No total mg or price per mg.Listed in stock
RICHPEP

Coupon terms unverified. Item eligibility and stacking unverified; no coupon included in this price.

Dates and offer terms

Price verified: not verified. Quantity verified: not verified.

Listing observed: Oct 9, 2026. Confirm availability with the seller.

Item terms verified: not verified. Eligibility: unknown. Stacking: unknown.

Shipping: not verified; seller charges excluded. Tax: not verified; excluded.

View product: Testagen at Limitless Life Nootropics (opens new tab)Exact merchant listingPartner customer link (opens new tab)Opens the partner referral page. Choose the exact product there; this is separate from the listing above.
Listing source

listing · Oct 9, 2026